W0101 is a novel insulin-like growth factor type 1 receptor (IGF-1R)-targeting ADC, which was designed to deliver cytotoxic MMAE to the IGF-1R-overexpressing cancer cells [8,49]. The gene discussed is IGF1R; the disease is cancer.